Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.

Grunebaum E, Roifman CM.

Immunol Allergy Clin North Am. 2010 Feb;30(1):63-73. doi: 10.1016/j.iac.2009.11.001.

PMID:
20113887
2.

Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.

Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Brown BS, Paul ME, Abramson SL, Ritz J, Shearer WT.

J Allergy Clin Immunol. 2008 Dec;122(6):1185-93. doi: 10.1016/j.jaci.2008.10.030.

PMID:
19084111
3.

Hematopoietic stem cell transplantation: 40 years of continuous progress and evolution.

Porta F, Locatelli F, Burgio GR.

Haematologica. 2008 Nov;93(11):1607-10. doi: 10.3324/haematol.13706. No abstract available.

4.

The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).

Keller MD, Chen DF, Condron SA, Liu N, Reinsmoen NL, Buckley RH.

J Clin Immunol. 2007 Jan;27(1):109-16. Epub 2006 Dec 27. Erratum in: J Clin Immunol. 2007 Nov;27(6):659.

PMID:
17191149
5.

Serial transplantation resulting in tolerance to an unrelated cord blood graft.

Goebel WS, Nelson RP Jr, Brahmi Z, Gowan DJ, Towell PJ, Robertson KA, Haut PR.

Transplantation. 2006 Jun 15;81(11):1596-9.

PMID:
16770250
6.

Unmanipulated HLA-haploidentical bone marrow transplantation for the treatment of fatal, nonmalignant diseases in children and adolescents.

Yabe H, Inoue H, Matsumoto M, Hamanoue S, Hiroi A, Koike T, Sako M, Fujiwara M, Ueda Y, Maruya E, Saji H, Kato S, Yabe M.

Int J Hematol. 2004 Jul;80(1):78-82.

PMID:
15293574
7.

Advances in the understanding and treatment of human severe combined immunodeficiency.

Buckley RH.

Immunol Res. 2000;22(2-3):237-51. Review.

PMID:
11339359
8.

[Determination of soluble HLA class I molecules in children in bone marrow transplantation].

Sedivá A, Starý J, Hromadníková I, Skalická A, Ghio M.

Cas Lek Cesk. 2000 Oct 11;139(20):630-4. Czech.

PMID:
11192758
9.

The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation.

Reisner Y, Bachar-Lustig E, Li HW, Aversa F, Velardi A, Martelli MF.

Ann N Y Acad Sci. 1999 Apr 30;872:336-48; discussion 348-50. Review.

PMID:
10372136
10.

Allogeneic bone marrow transplantation: relation between chimaerism and immunity.

Vossen J.

Verh K Acad Geneeskd Belg. 1998;60(2):111-43; discussion 143-5. Review.

PMID:
9703764
11.

Detection of donor-derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantation.

Emile JF, Haddad E, Fraitag S, Canioni D, Fischer A, Brousse N.

Br J Haematol. 1997 Aug;98(2):480-4.

PMID:
9266954
12.

In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID).

Dickinson AM, Reid MM, Abinun M, Peak J, Brigham K, Dunn J, Cant AJ.

Bone Marrow Transplant. 1997 Feb;19(4):323-9.

13.

Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.

Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.

Pediatrics. 1996 Sep;98(3 Pt 1):420-8.

PMID:
8784367
14.

Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells.

Reisner Y, Martelli MF.

Immunol Today. 1995 Sep;16(9):437-40. Review.

PMID:
7546208
15.

Treatment of Omenn syndrome by bone marrow transplantation.

Gomez L, Le Deist F, Blanche S, Cavazzana-Calvo M, Griscelli C, Fischer A.

J Pediatr. 1995 Jul;127(1):76-81.

PMID:
7608815
16.
17.

Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients.

Klein C, Cavazzana-Calvo M, Le Deist F, Jabado N, Benkerrou M, Blanche S, Lisowska-Grospierre B, Griscelli C, Fischer A.

Blood. 1995 Jan 15;85(2):580-7. Review.

18.

HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases.

Giri N, Vowels M, Ziegler JB, Ford D, Lam-Po-Tang R.

Aust N Z J Med. 1994 Feb;24(1):26-30.

PMID:
8002854
19.

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal Malefyt R, de Vries JE, Roncarolo MG.

J Exp Med. 1994 Feb 1;179(2):493-502.

20.

Bone marrow transplantation in children using "HLA-partially-matched" family donors.

Martinetti M, Locatelli F, Pizzochero C, Prete L, Ambroselli F, Giani S, Comoli P, Salvaneschi L.

Bone Marrow Transplant. 1993;11 Suppl 1:93-4. No abstract available.

PMID:
8448562
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk